AAMS Neurology & Neurosciences · Vol. 7 · Issue 3 · 2026-03-01
Stem Cell Therapy for Amyotrophic Lateral Sclerosis: Phase II Efficacy Results
Andersson P, Kato N, Abdi-Rashid H
Sahlgrenska Academy, Gothenburg, Sweden; University of Tokyo, Tokyo, Japan; Mogadishu University, Mogadishu, Somalia
Abstract
Phase II randomized controlled trial evaluating intrathecal mesenchymal stem cell transplantation in 120 patients with ALS, assessing functional decline rates and survival.
Keywords: ALS, stem cell therapy, mesenchymal stem cells, phase II, motor neuron disease
Full Text